These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 208767)

  • 1. Mammary tumor virus oncogenesis and tumor immunogenicity in three sublines of the C3H mouse.
    Vaage J; Medina D
    Cancer Res; 1978 Aug; 38(8):2443-7. PubMed ID: 208767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammary tumorigenesis and tumor morphology in four C3H sublines with or without exogenous mammary tumor virus.
    Vaage J; Smith GH; Asch BB; Teramoto Y
    Cancer Res; 1986 Apr; 46(4 Pt 2):2096-100. PubMed ID: 2418961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of in vitro and in vivo studies of antigens relevant to the control of murine breast cancer.
    Stutman O
    Cancer Res; 1976 Feb; 36(2 pt 2):739-47. PubMed ID: 175934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced immune reactivity to hepatoma 22a cells in MTV-infected compared with MTV-free C3H mice.
    Lavrovsky VA; Viksler VK
    Immunology; 1981 Dec; 44(4):671-6. PubMed ID: 6274791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Increased immunologic reactivity against hepatoma 22A cells in MTV-infected C3H mice in comparison to MTV-free mice].
    Lavrovskiĭ VA; Viksler VKh
    Biull Eksp Biol Med; 1980 Oct; 90(10):467-9. PubMed ID: 6252986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of early thymectomy on the growth of transplanted mammary gland tumors developing in mouse line C3Hf].
    Videlets II; Gruntenko EV
    Biull Eksp Biol Med; 1976 Jun; 81(6):721-3. PubMed ID: 182306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherent changes in the in vivo growth characteristics of C3H/He mammary carcinomas.
    Vaage J
    Cancer Res; 1980 Oct; 40(10):3495-3501. PubMed ID: 7438036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing transplantation characteristics with serial in vivo passage of C3H/He mammary carcinomas.
    Vaage J
    Cancer Res; 1978 Oct; 38(10):3264-8. PubMed ID: 688216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus oncogenesis and tumor immunogenicity in the mouse mammary tumor system.
    Vaage J; Medina D
    Cancer Res; 1974 Jun; 34(6):1319-24. PubMed ID: 4363654
    [No Abstract]   [Full Text] [Related]  

  • 11. Natural immunity in the oncornavirus-infected mouse.
    Blair PB
    Cancer Res; 1976 Feb; 36(2 pt 2):734-8. PubMed ID: 175933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences of milk-transmitted murine mammary tumor virus (MMTV) among mouse strains.
    Sayama K; Takeda Y; Hashimoto H; Kaneko T; Matsuzawa A
    In Vivo; 1999; 13(2):135-40. PubMed ID: 10363169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autogenous antibodies against the murine mammary tumor virus in strains of mice with low incidences of mammary tumors.
    Michalides R; Wagenaar E; Nusse R
    J Natl Cancer Inst; 1979 Apr; 62(4):935-41. PubMed ID: 219283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
    McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J
    J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunology of spontaneous mammary carcinomas in mice: immunogenicity of mammary tumor virus-contaning tissues in mammary tumor virus-free C3H-2 hosts.
    Lavrin DH
    Cancer Res; 1970 Apr; 30(4):1156-62. PubMed ID: 4323351
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro detection of immune responses to MTV-induced mammary tumors: qualitative differences in response detected by time studies.
    Blair PB; Lane MA
    J Immunol; 1975 Jan; 114(1 Pt 1):17-23. PubMed ID: 163276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of mammary tumor cultures from four mouse strains infected with mammary tumor virus.
    Yagi MJ
    Cancer Res; 1975 Feb; 35(2):370-3. PubMed ID: 162873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated growth of mammary tumor cells in normal and athymic mice after treatment in vitro with dexamethasone.
    Gillette RW; Wunderlich DA
    Cancer Res; 1978 Oct; 38(10):3146-9. PubMed ID: 80260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between tumor growth characteristics and preferential sites of growth.
    Vaage J
    J Natl Cancer Inst; 1984 May; 72(5):1199-203. PubMed ID: 6585595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of immunity induced by neuraminidase-treated lymphosarcoma cells in C3H (MTV+) and C3H (MTV-) mice.
    Bekesi JG; Roboz JP; Holland JF
    Isr J Med Sci; 1976; 12(4-5):288-303. PubMed ID: 181351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.